Current updates and research on plant-based vaccines for coronavirus disease 2019
10.7774/cevr.2021.10.1.13
- Author:
Asqwin Uthaya KUMAR
1
;
Kirthikah KADIRESEN
;
Wen Cong GAN
;
Anna Pick KIONG LING
Author Information
1. Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, International Medical University, Kuala Lumpur, Malaysia
- Publication Type:Review article
- From:Clinical and Experimental Vaccine Research
2021;10(1):13-23
- CountryRepublic of Korea
- Language:English
-
Abstract:
The primary outbreak of severe acute respiratory syndrome coronavirus 2, causing pneumonia-like symptoms in patients named coronavirus disease 2019 (COVID-19) had evolved into a global pandemic. COVID-19 has surpassed Middle East respiratory syndrome and severe acute respiratory syndrome in terms of rate and scale causing more than one million deaths.Development of an effective vaccine to fight against the spread of COVID-19 is the main goal of many countries around the world and plant-based vaccines are one of the available methods in vaccine developments. Plant-based vaccine has gained its reputation among researchers for its known effective manufacturing process and cost effectiveness. Many companies around the world are participating in the race to develop an effective vaccine by using the plant system. This review discusses different approaches used as well as highlights the challenges faced by various companies and research groups in developing the plant-based COVID-19 vaccine.
